Satellos Bioscience Inc.
MSLE
$7.28
$0.020.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.30M | -5.82M | -5.61M | -6.14M | -4.46M |
| Total Depreciation and Amortization | 0.00 | 3.00K | 0.00 | 1.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 777.00K | 889.00K | 446.00K | 639.00K | -43.00K |
| Change in Net Operating Assets | -735.00K | 803.00K | 319.00K | -1.87M | -725.00K |
| Cash from Operations | -7.26M | -4.13M | -4.84M | -7.37M | -5.22M |
| Capital Expenditure | 0.00 | -3.00K | -3.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.56M | -15.33M | 8.48M | -- | -8.94M |
| Cash from Investing | -2.56M | -15.33M | 8.47M | -- | -8.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 147.00K | 700.00K | 1.39M | 2.00K | 30.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 6.92M |
| Cash from Financing | 147.00K | 700.00K | 1.39M | 2.00K | 37.39M |
| Foreign Exchange rate Adjustments | 171.00K | -155.00K | 484.00K | 3.00K | -529.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.50M | -18.91M | 5.51M | -7.36M | 22.71M |